Core One Labs Inc
Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and op… Read more
Core One Labs Inc (CLABF) - Total Assets
Latest total assets as of December 2023: $7.40 Million USD
Based on the latest financial reports, Core One Labs Inc (CLABF) holds total assets worth $7.40 Million USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Core One Labs Inc - Total Assets Trend (2012–2023)
This chart illustrates how Core One Labs Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Core One Labs Inc - Asset Composition Analysis
Current Asset Composition (March 2023)
Core One Labs Inc's total assets of $7.40 Million consist of 14.0% current assets and 86.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 7.7% |
| Accounts Receivable | $183.57K | 2.3% |
| Inventory | $3.34K | 0.0% |
| Property, Plant & Equipment | $115.88K | 1.4% |
| Intangible Assets | $5.70 Million | 70.3% |
| Goodwill | $591.59K | 7.3% |
Asset Composition Trend (2012–2023)
This chart illustrates how Core One Labs Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Core One Labs Inc's current assets represent 14.0% of total assets in 2023, a decrease from 87.5% in 2012.
- Cash Position: Cash and equivalents constituted 7.7% of total assets in 2023, down from 83.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 77.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is intangible assets at 70.3% of total assets.
Core One Labs Inc Competitors by Total Assets
Key competitors of Core One Labs Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Core One Labs Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Core One Labs Inc generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Core One Labs Inc is currently not profitable relative to its asset base.
Core One Labs Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.25 | 1.38 | 1.42 |
| Quick Ratio | 0.25 | 1.38 | 1.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.31 Million | $ 542.09K | $ 2.04 Million |
Core One Labs Inc - Advanced Valuation Insights
This section examines the relationship between Core One Labs Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.21 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 6.6% |
| Total Assets | $8.11 Million |
| Market Capitalization | $500.00 USD |
Valuation Analysis
Below Book Valuation: The market values Core One Labs Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Core One Labs Inc's assets grew by 6.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Core One Labs Inc (2012–2023)
The table below shows the annual total assets of Core One Labs Inc from 2012 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-03-31 | $8.11 Million | +6.61% |
| 2022-03-31 | $7.61 Million | -20.09% |
| 2021-03-31 | $9.52 Million | -46.51% |
| 2020-03-31 | $17.80 Million | -15.48% |
| 2019-03-31 | $21.06 Million | +60.42% |
| 2018-03-31 | $13.13 Million | +686.42% |
| 2017-03-31 | $1.67 Million | +16.48% |
| 2016-03-31 | $1.43 Million | +265.71% |
| 2015-03-31 | $391.95K | +459.74% |
| 2014-03-31 | $70.02K | -86.88% |
| 2013-03-31 | $533.61K | -35.19% |
| 2012-03-31 | $823.37K | -- |